Zota Health Care Schedules Q1FY27 Earnings Call for August 14
Zota Health Care Limited will announce its Q1FY27 results on August 13, 2026. An Earnings Call is scheduled for August 14, 2026, at 11:30 hrs. IST, to discuss the financial performance. Key management personnel will participate in the call.
This is a standard procedural announcement regarding the scheduling of an earnings call. It does not contain any new material financial information or strategic decisions that would significantly impact the company's operations or stock price at this stage.
The announcement is a routine intimation about a scheduled conference call for Q1FY27 results, which is a standard corporate event. No specific financial performance data or forward-looking statements with significant positive or negative implications are included in this particular announcement.
Zota Health Care Limited announced that it will host an Earnings Call to discuss its financial results for the first quarter ended June 30, 2026. The results are scheduled to be announced on August 13, 2026. The subsequent Earnings Call will take place on Friday, August 14, 2026, at 11:30 hrs. IST.
The call, expected to last 60 minutes, will feature participation from Mr. Himanshu Zota (Founder and Whole-time Director), Mr. Moxesh Zota (Managing Director), and Dr. Sujit Paul (Group Chief Executive Officer). The company encourages participants to dial in 10 minutes prior to the start time. Dial-in numbers provided are +91 22 6280 1107 / +91 22 7115 8008. A pre-registration facility is also available via a provided link for direct connection to the call.
Zota Health Care Limited, headquartered in Surat, is a pharmaceutical company involved in the development, manufacturing, and marketing of pharmaceutical, ayurvedic, nutraceutical, and over-the-counter products. The company operates through marketing, export, and a retail pharmacy chain, Davaindia.
What to do with a filing like this
Zota Health Care LImited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Zota Health Care LImited. Read the original for the full detail.